de Donato M, Kouchaeknejad A, de Donato A, Van Der Walt G, Puighermanal E
Bio Protoc. 2025; 15(4):e5218.
PMID: 40034468
PMC: 11873448.
DOI: 10.21769/BioProtoc.5218.
Kayser E, Mulholland M, Olkhova E, Chen Y, Coulson H, Cairns O
Orphanet J Rare Dis. 2025; 20(1):65.
PMID: 39930437
PMC: 11812209.
DOI: 10.1186/s13023-025-03582-x.
Huff A, Oliveira L, Karlen-Amarante M, Ebiala F, Ramirez J, Kalume F
Exp Neurol. 2024; 385:115123.
PMID: 39710245
PMC: 11781966.
DOI: 10.1016/j.expneurol.2024.115123.
Warwick A, Bomze H, Wang L, Hao Y, Stinnett S, Gospe 3rd S
Sci Rep. 2024; 14(1):24114.
PMID: 39406814
PMC: 11480089.
DOI: 10.1038/s41598-024-75916-x.
Henke M, Prigione A, Schuelke M
J Inherit Metab Dis. 2024; 47(6):1292-1321.
PMID: 39385390
PMC: 11586605.
DOI: 10.1002/jimd.12804.
Ndufs4 inactivation in glutamatergic neurons reveals swallow-breathing discoordination in a mouse model of Leigh Syndrome.
Huff A, Oliveira L, Karlen-Amarante M, Ebiala F, Ramirez J, Kalume F
bioRxiv. 2024; .
PMID: 39314482
PMC: 11419062.
DOI: 10.1101/2024.09.11.612506.
Leigh has no Brakes: Impaired Inhibition in a Mouse Model of Leigh Syndrome Leads to Enhanced Seizure Sensitivity.
Buchanan G
Epilepsy Curr. 2024; 24(4):298-300.
PMID: 39309059
PMC: 11412401.
DOI: 10.1177/15357597241257031.
Cannabidiol ameliorates mitochondrial disease via PPARγ activation in preclinical models.
Puighermanal E, Luna-Sanchez M, Gella A, Van Der Walt G, Urpi A, Royo M
Nat Commun. 2024; 15(1):7730.
PMID: 39231983
PMC: 11375224.
DOI: 10.1038/s41467-024-51884-8.
Evaluating the efficacy of vatiquinone in preclinical models of mitochondrial disease.
Kayser E, Chen Y, Mulholland M, Truong V, James K, Hanaford A
Res Sq. 2024; .
PMID: 38883711
PMC: 11177993.
DOI: 10.21203/rs.3.rs-4202689/v1.
Interleukin-6-elicited chronic neuroinflammation may decrease survival but is not sufficient to drive disease progression in a mouse model of Leigh syndrome.
Aguilar K, Canal C, Comes G, Diaz-Clavero S, Llanos M, Quintana A
J Inflamm (Lond). 2024; 21(1):1.
PMID: 38212783
PMC: 10782699.
DOI: 10.1186/s12950-023-00369-4.
Defective function of α-ketoglutarate dehydrogenase exacerbates mitochondrial ATP deficits during complex I deficiency.
Piroli G, Manuel A, McCain R, Smith H, Ozohanics O, Mellid S
Redox Biol. 2023; 67:102932.
PMID: 37883842
PMC: 10618796.
DOI: 10.1016/j.redox.2023.102932.
Vestibular CCK signaling drives motion sickness-like behavior in mice.
Machuca-Marquez P, Sanchez-Benito L, Menardy F, Urpi A, Girona M, Puighermanal E
Proc Natl Acad Sci U S A. 2023; 120(44):e2304933120.
PMID: 37847729
PMC: 10622874.
DOI: 10.1073/pnas.2304933120.
Elevated susceptibility to exogenous seizure triggers and impaired interneuron excitability in a mouse model of Leigh syndrome epilepsy.
Manning A, Han V, Stephens A, Wang R, Bush N, Bard M
Neurobiol Dis. 2023; 187:106288.
PMID: 37704057
PMC: 10621616.
DOI: 10.1016/j.nbd.2023.106288.
Glutamine metabolism in diseases associated with mitochondrial dysfunction.
Bornstein R, Mulholland M, Sedensky M, Morgan P, Johnson S
Mol Cell Neurosci. 2023; 126:103887.
PMID: 37586651
PMC: 10773532.
DOI: 10.1016/j.mcn.2023.103887.
Neurological Phenotypes in Mouse Models of Mitochondrial Disease and Relevance to Human Neuropathology.
Olkhova E, Smith L, Bradshaw C, Gorman G, Erskine D, Ng Y
Int J Mol Sci. 2023; 24(11).
PMID: 37298649
PMC: 10254022.
DOI: 10.3390/ijms24119698.
Continuous Hypoxia Reduces Retinal Ganglion Cell Degeneration in a Mouse Model of Mitochondrial Optic Neuropathy.
Warwick A, Bomze H, Wang L, Klingeborn M, Hao Y, Stinnett S
Invest Ophthalmol Vis Sci. 2022; 63(13):21.
PMID: 36538003
PMC: 9769749.
DOI: 10.1167/iovs.63.13.21.
Microglial response promotes neurodegeneration in the Ndufs4 KO mouse model of Leigh syndrome.
Aguilar K, Comes G, Canal C, Quintana A, Sanz E, Hidalgo J
Glia. 2022; 70(11):2032-2044.
PMID: 35770802
PMC: 9544686.
DOI: 10.1002/glia.24234.
Leukocytes mediate disease pathogenesis in the Ndufs4(KO) mouse model of Leigh syndrome.
Stokes J, Bornstein R, James K, Park K, Spencer K, Vo K
JCI Insight. 2022; 7(5).
PMID: 35050903
PMC: 8983133.
DOI: 10.1172/jci.insight.156522.
Differential effects of mTOR inhibition and dietary ketosis in a mouse model of subacute necrotizing encephalomyelopathy.
Bornstein R, James K, Stokes J, Park K, Kayser E, Snell J
Neurobiol Dis. 2021; 163:105594.
PMID: 34933094
PMC: 8770160.
DOI: 10.1016/j.nbd.2021.105594.
Non-synaptic Cell-Autonomous Mechanisms Underlie Neuronal Hyperactivity in a Genetic Model of -Driven Intractable Epilepsy.
Roy A, Han V, Bard A, Wehle D, Smith S, Ramirez J
Front Mol Neurosci. 2021; 14:772847.
PMID: 34899181
PMC: 8662737.
DOI: 10.3389/fnmol.2021.772847.